Announcements Trials

Browse Landscape

Phase

Phase NA 1 Phase 3 1 Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 112 Lymphoma, Large B-Cell, Diffuse 77 Precursor Cell Lymphoblastic Leukemia-Lymphoma 67 Leukemia 47 Burkitt Lymphoma 45 Lymphoma, Non-Hodgkin 35 Lymphoma, Mantle-Cell 28 Lymphoma, Follicular 27 Hodgkin Disease 22 Neuroblastoma 19 Central Nervous System Neoplasms 19 Sarcoma 18 Lymphoma, B-Cell 13 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 12 Lymphoma, Large-Cell, Immunoblastic 12 Lymphoma, T-Cell, Peripheral 11 Lymphoma, Large-Cell, Anaplastic 11 Neoplasms 10 Multiple Myeloma 10 Dendritic Cell Sarcoma, Interdigitating 10 Sarcoma, Ewing 9 Rhabdomyosarcoma 9 Retinoblastoma 9 Medulloblastoma 9 Lymphoma, B-Cell, Marginal Zone 8 Leukemia, Biphenotypic, Acute 8 Recurrence 7 Neuroectodermal Tumors, Primitive, Peripheral 7 Lymphoma, T-Cell 7 HIV Infections 7

Interventions

Carboplatin 3 Radiotherapy 2 Doxorubicin 2 tipifarnib 1 etoposide phosphate 1 becatecarin 1 Vincristine 1 Temozolomide 1 Tamoxifen 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 RMP 7 1 Perfusion Magnetic Resonance Imaging 1 Oxaliplatin 1 Megestrol Acetate 1 Lenalidomide 1 Irinotecan 1 Immunologic Techniques 1 Etoposide 1 Endostatins 1 Dynamic Contrast Enhanced Magnetic Resonance Imaging 1 Cyproheptadine 1 Cisplatin 1 Cilengitide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Optic Nerve Glioma × Vincristine × Clear all

NCT05278715 2024-10-15

Modified CV Regimen in Optic Pathway Glioma

Beijing Sanbo Brain Hospital

Phase 2 Recruiting

Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡